Belvin Marcia
SVP, Chief Scientific Officer at CTMX
- Sold, on record
- $294k
- Dollars the filings state
- Form 4 sales
- 7
- Latest Mar 17, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- CTMXCytomX Therapeutics, Inc.SVP, Chief Scientific Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale CTMXNo planSep 22, 2023 2023
Sold 4,119 shares at $1.30 ($5k)
Belvin Marcia, SVP, Chief Scientific Officer
No 10b5-1 planSold 2.7% of holdings ($198k position)147,951 shares leftFirst sale on recordFiling
- 2 Form 4 sale CTMXNo planDec 20, 2023 +89 days
Sold 4,077 shares at $1.38 ($6k)
Belvin Marcia, SVP, Chief Scientific Officer
No 10b5-1 planSold 2.6% of holdings ($220k position)155,124 shares leftFiling
- 3 Form 4 sale CTMXNo planMar 19, 2024 +90 days
Sold 12,795 shares at $2.09 ($27k)
Belvin Marcia, SVP, Chief Scientific Officer
No 10b5-1 planSold 7.1% of holdings ($379k position)168,579 shares leftFiling
- 4 Form 4 sale CTMXNo planAug 20, 2024 +154 days
Sold 4,181 shares at $1.23 ($5k)
Belvin Marcia, SVP, Chief Scientific Officer
No 10b5-1 planSold 2.3% of holdings ($221k position)175,648 shares left1x usual sizeFiling
- 5 Form 4 sale CTMXUnusualMar 18, 2025 +210 days
Sold 19,512 shares at $0.60 ($12k)
Belvin Marcia, SVP, Chief Scientific Officer
No 10b5-1 planSold 7.3% of holdings ($161k position)248,636 shares left4.7x usual sizeFiling
- 6 Form 4 sale CTMXUnusualJun 16, 2025 +90 days
Sold 13,884 shares at $2.69 ($37k)
Belvin Marcia, SVP, Chief Scientific Officer
No 10b5-1 planSold 4.9% of holdings ($770k position)272,252 shares left3.3x usual sizeFiling
- 7 Form 4 sale CTMXNo planMar 17, 2026 +274 days
Sold 31,492 shares at $6.42 ($202k)
Belvin Marcia, SVP, Chief Scientific Officer
No 10b5-1 planSold 9.5% of holdings ($2.1M position)300,760 shares left2.4x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (7)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2026 | Mar 19, 2026 | CTMX | SVP, Chief Scientific Officer | Form 4 sale | 31,492 | $202k | 9.5% | No plan | SEC |
| Jun 16, 2025 | Jun 17, 2025 | CTMX | SVP, Chief Scientific Officer | Form 4 sale | 13,884 | $37k | 4.9% | Unusual | SEC |
| Mar 18, 2025 | Mar 20, 2025 | CTMX | SVP, Chief Scientific Officer | Form 4 sale | 19,512 | $12k | 7.3% | Unusual | SEC |
| Aug 20, 2024 | Aug 22, 2024 | CTMX | SVP, Chief Scientific Officer | Form 4 sale | 4,181 | $5k | 2.3% | No plan | SEC |
| Mar 19, 2024 | Mar 21, 2024 | CTMX | SVP, Chief Scientific Officer | Form 4 sale | 12,795 | $27k | 7.1% | No plan | SEC |
| Dec 20, 2023 | Dec 22, 2023 | CTMX | SVP, Chief Scientific Officer | Form 4 sale | 4,077 | $6k | 2.6% | No plan | SEC |
| Sep 22, 2023 | Sep 22, 2023 | CTMX | SVP, Chief Scientific Officer | Form 4 sale | 4,119 | $5k | 2.7% | No plan | SEC |